Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
- UCL School of Pharmacy
- Faculty of Life Sciences
Professor Kostarelos has been invited Fellow of the Royal Society of Medicine (FRSM), Fellow of the Institute of Nanotechnology (FIoN) and Fellow of the Royal Society of Arts (FRSA) all in the United Kingdom. In 2010 he was awarded the Japanese Society for the Promotion of Science (JSPS) Professorial Fellowship with the National Institute of Advanced Industrial Science and Technology (AIST) in Tsukuba, Japan. Prof. Kostarelos is the Founding and Senior Editor of the journal Nanomedicine (ISI 2011 Impact Factor: 5.055) and sits on the Editorial Board of Archives in Toxicology, The Journal of Liposome Research, The International Journal of Nanomedicine and Frontiers in Neuroengineering.
He obtained his Diploma in Chemical Engineering and PhD from the Department of Chemical Engineering at Imperial College London, studying the steric stabilization of liposomes using block copolymer molecules. He carried out his postdoctoral training in various medical institutions in the United States and has worked closely with Professors Th.F. Tadros (ICI plc, UK), P.F. Luckham (Imperial College London), D. Papahadjopoulos (UCSF, USA), G. Sgouros (Memorial Sloan-Kettering, NY, USA) and R.G. Crystal (Weill Medical College of Cornell University, NY, USA).
Following his promotion to Assistant Professor of Genetic Medicine & Chemical Engineering in Medicine at Cornell University Weill Medical College, he relocated to the UK as the Deputy Director of Imperial College Genetic Therapies Centre. Professor Kostarelos joined the Centre for Drug Delivery Research and the Department of Pharmaceutics in 2003 as the Deputy Head of the Centre. He was promoted to the Personal Chair of Nanomedicine and Head of the Centre in 2007.
Professor Kostarelos is leading the Nanomedicine Laboratory. His research portfolio consists of development of novel viral and non-viral gene therapy vectors, delivery and genetic manipulation of embryonic and progenitor stem cells, advanced delivery systems for radio- and chemo-therapeutic agents against cancer, descriptive and predictive modelling of delivery systems’ pharmacological performance. During his career he has focused on the engineering of delivery systems for drugs, vitamins, radionuclides and genes towards therapeutic applications.
Prof.K.Kostarelos and Nanomedicine
Lab members lecture for the Undergraduate MPharm Degree and the
Postgraduate Degrees offered by the School of Pharmacy. Courses organised
and delivered by the Nanomedicine Lab academic staff, include: Nanomedicine
& Targeted Delivery (Full Module, Spring Term).
Prof.K.Kostarelos was also Course Director of the MSc in Drug Delivery programme from 2003-2008.
|01-JUL-2007||Professor & Chair of Nanomedicine||School of Pharmacy||University College London , United Kingdom|
|01-OCT-2005||Head, Centre for Drug Delivery Research||Pharmaceutics||UCL School of Pharmacy, United Kingdom|
|01-OCT-2003 – 01-JUL-2007||Lecturer & Senior Lecturer||Pharmaceutics||UCL School of Pharmacy, United Kingdom|
|01-OCT-2002 – 01-OCT-2003||Deputy Director||Imperial College Genetic Therapies Centre||Imperial College London, United Kingdom|
|01-JAN-2000 – 01-DEC-2000||Director, Bioengineering Core||Arthur & Rochelle Belfer Gene Therapy Core Facility||Weill Medical College of Cornell University , United States|
|01-OCT-1998 – 01-MAY-2000||Instructor||Division of Pulmonary & Critical Care Medicine||New York - Presbyterian Hospital, United States|
|01-OCT-1998 – 01-JAN-2001||Assistant Professor of Genetic Medicine||Institute of Genetic Medicine||Weill Medical College of Cornell University , United States|